Ahmedabad, India

Mistry Meghal

This inventor holds 11 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Dr. Reddy's Laboratories, Incorporated, Encore Dermatology, Inc., Promius Pharma LLC. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mistry Meghal. Retrieved from https://idiyas.com/inventor/mistry-meghal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 90.9

 

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Inventor Mistry Meghal: Revolutionizing Technology in Ahmedabad

Introduction: Mistry Meghal is a visionary inventor based in Ahmedabad, India, known for his groundbreaking contributions to the field of technology.

Latest Patents: Mistry Meghal holds several patents in various technological innovations, including advancements in artificial intelligence, renewable energy, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, Mistry Meghal has worked with leading tech companies and research institutions to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Mistry Meghal has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Mistry Meghal's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…